{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Register online
|
Log in
|
My Prescrire
Issue contents
Current issue
Last 12 issues
All issues
Topics
Annual Prescrire Awards
Advancing healthcare policy
Positions
Mediator° - the criminal trial
Drugs to avoid: 2022 update
Spotlight
About Prescrire
Who are we?
How we work
AMP: non-profit
Financing
No conflicts of interest
Where to find us
About Prescrire International
Testimonials
Prescrire events
A global network
Offers
Subscribe now
Solidarity Subscription Rate
Subscribers: register online
Prescrire's other products
Free Special Edition
Sign up to receive the newsletter
english.prescrire.org
>
Drugs to avoid : 2022 update
>
Drugs to avoid
Drugs to avoid
in the name of better patient care
- 2022 update
The result of a reliable, rigourous and independent methodology
Drugs to avoid
2022 update
Drugs to avoid in the name of better patient care: 2022 update
To make it easier to choose quality care, and to prevent disproportionate harm to patients, Prescrire has published its annual update of drugs to avoid.
Learn more...
Drugs to avoid: a reliable, rigorous and independent methodology
What is the purpose of this annual review? What data sources and methodology do we use to assess a drug's harm-benefit balance?
Learn more...
Drugs to avoid: main changes in the 2022 update
What are the main differences between the 2021 and 2022 versions?
Learn more...
Download the full text of the 2022 update as a PDF
Download the full review
> FREE
Sitemap
|
Terms of use
|
Contact
|
Top of page
Prescrire
Your change of address has been received and will be processed promptly but will not appear instantaneously
Prescrire
Your message has been sent